Biora Therapeutics Competitors and Similar CompaniesClear all

GeneDx's competitors and similar companies include Ambry Genetics, Natera, Myriad Genetics and Invitae.

	GeneDx GeneDx is a company operating in the genetics and genomics industry.	Ambry Genetics Ambry Genetics is a company that provides genetic testing solutions.	Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology.	Myriad Genetics Myriad Genetics is a company that develops and offers genetic tests.	Invitae Invitae is a company engaged in medical genetic testing.
Founding Date	Founding Date 2000	Founding Date 1999	Founding Date 2004	Founding Date 1991	Founding Date 2010
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics medical diagnostics	Tags Healthcare genetics healthtech medical diagnostics women's health	Tags Healthcare genetics medical diagnostics medical imaging oncology	Tags Healthcare biotech genetics medical diagnostics
Locations	Locations Gaithersburg, US HQ	Locations Aliso Viejo, US HQ Aliso Viejo, US	Locations Austin, US HQ San Carlos, US	Locations Salt Lake City, US HQ Paris, FR Munich, DE Tokyo, JP Amsterdam, NL Zürich, CH	Locations San Francisco, US HQ
Employees	Employees 8964% increase	Employees 9094% increase	Employees 3,28211% increase	Employees 2,700	Employees 8601% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 15.4 b	Valuation ($) 2 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2.3b (FY, 2025)	Revenue (est.) $824.5m (FY, 2025)	Revenue (est.) $516.3m (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $247.9m (FY, 2025)	Cost of goods $417.3m (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $576.6m (FY, 2025)	Gross profit $99m (FY, 2022)
Net income	Net income N/A	Net income N/A	Net income ($208.2m) (FY, 2025)	Net income ($365.9m) (FY, 2025)	Net income ($3.1b) (FY, 2022)
Operating ⚠
Facilities Leased, sq. ft.	Facilities Leased, sq. ft. N/A	Facilities Leased, sq. ft. N/A	Facilities Leased, sq. ft. 272 k (FY, 2021)	Facilities Leased, sq. ft. 500.1 k (FY, 2022)	Facilities Leased, sq. ft. N/A
Tests	Tests 561 (Oct, 2022)	Tests N/A	Tests 489.3 k (Q1, 2022)	Tests N/A	Tests N/A
Trademarks (US)	Trademarks (US) 8 (Oct, 2022)	Trademarks (US) 65 (Aug, 2022)	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 154.1m	Total funding raised N/A	Total funding raised $ 363.1m